Let Alexander Law Group Protect Your Rights
Onglyza, a common medication used to treat type 2 diabetes, and its sister medication, Kombiglyze, have both been linked to an increased risk of cardiovascular disease. In a recent study, almost 30% OF TESTED USERS REPORTED EXPERIENCING A MAJOR CARDIOVASCULAR EVENT while using the drug. Legal claims against the parent company, AstraZeneca, include production of a dangerous medication, failure to warn the public, improper marketing of a medication and marketing of a drug despite the knowledge of risk.
If you have taken Onglyza or Kombiglyze and have experienced a cardiovascular event or illness, you may be entitled to financial compensation.
Contact the team of Onglyza specialists at Alexander Law Group to get the compensation you deserve.